Compare TIGO & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIGO | RGC |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | Luxembourg | Hong Kong |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 11.5B |
| IPO Year | 1997 | 2020 |
| Metric | TIGO | RGC |
|---|---|---|
| Price | $77.76 | $29.79 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $68.30 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 179.3K |
| Earning Date | 05-07-2026 | 10-31-2025 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.90 | N/A |
| Revenue Next Year | $4.05 | N/A |
| P/E Ratio | $10.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.26 | $9.39 |
| 52 Week High | $84.44 | $950.00 |
| Indicator | TIGO | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 53.71 |
| Support Level | $46.19 | $22.43 |
| Resistance Level | N/A | $37.83 |
| Average True Range (ATR) | 2.80 | 3.83 |
| MACD | -0.13 | 0.31 |
| Stochastic Oscillator | 43.46 | 38.42 |
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia, Nicaragua, Panama, El Salvador, Guatemala, Paraguay, Colombia, Ecuador, Uruguay, and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 140 million people, serving nearly 50 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has also formed a joint venture to acquire Telefonica's operations in Chile.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.